A new study has popped up in the field of medicine which attempts to explore the potential of a certain cellular process - known as endocytosis - to pave the way towards a revolutionary treatment approach that could counter the debilitating amyotrophic lateral sclerosis (ALS) disease.The unexpected findings have come to the horizons thanks to a study by researchers from the University of Arizona.ALS is the progressive degeneration of motor neurons that causes people to lose the ability to move and eventually speak, eat and breathe.Within the neuronal cells of patients with ALS and other neurodegenerative diseases, two proteins -- TDP-43 and FUS -- are often found in bundles of molecular junk called aggregates, which can accumulate to deadly levels."It's not clear yet if TDP-43 aggregates themselves are truly toxic or a sign that things have gotten really bad in a cell, and this is its last Hail Mary trying to keep things in order," said Ross Buchan, assistant professor of molecular ...
